ENLV
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. (ENLV) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 17.8 (oversold), with 0/3 trend checks passing.
ENLV with MA50 and MA200
Key levels & signals
Enlivex Therapeutics Ltd. (ENLV) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $5.84, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 41.5% and below the 200-day moving average by 57.6%.
ENLV currently has an RSI reading of 17.8, which places it in a deeply oversold zone. That can sometimes lead to bounce-watch setups, but it can also reflect genuine weakness, so the chart still needs proper confirmation rather than hope alone.
For traders reviewing ENLV next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
ENLV shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about ENLV
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.